Dr. Hillary Kunis, a Providers Clinical Support System Clinical expert, explains the benefits of naloxone, a medication that can immediately revive a person who has overdosed on an opioid
At the conclusion of this activity, learners should be able to:
- Review addiction identification and evidence-based treatments.
- Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
- Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
- Explain the process of buprenorphine induction as well as stabilization and maintenance.
- Discuss other approved antagonist and agonist medications to treat OUD.
- Discuss basic office protocols including medical record documentation and confidentially.
- Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
- Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.
Effective October 2, 2018, California physicians must consult California’s PDMP (the Controlled Substance Utilization Review and Evaluation System, or CURES) – prior to prescribing Schedule II, III or IV controlled substances. The California Medical Association recently co-hosted a live CURES webinar with the California Department of Justice and the Medical Board of California regarding this new duty-to-consult requirement.
Substance Abuse and Mental Health Services Administration (SAMHSA)
The 12-hour Prescribing and Pharmacology course is designed for physicians of all specialties, physician assistants and certified registered nurse practitioners and nurse midwives*.
Buscar Tratamiento De Calidad Para Trastornos De Uso De Sustancias
This program will cover topics in Pain Management including: Pain Assessment, Opioid Titration, Understanding and Managing Adverse Effects of Opioid Analgesics, and Achieving Balance: Under or Overtreatment of Pain in Oncology.
The AAP has been a member and active participant in the AMA’s Task Force to Reduce Opioid Abuse. The AAP is involved in the task force’s efforts to:
• educate physicians about safe opioid prescribing practices;
• educate state policymakers about the importance of effective prescription drug monitoring programs (PDMPs);
• educate physicians about the importance of using PDMPs; and
• encourage widespread community access of naloxone.
The AAP is a partner in this campaign, which was launched in 2012 by The Partnership at Drugfree.org. The Medicine Abuse Project aims to curb the abuse of medicine. The Web site houses a suite of comprehensive resources tailored to parents, health professionals, educators, and community leaders, to help them learn about and address the problem.
Available in both English and Spanish, this poster is meant to be hung in the pediatric office for families to see. It is designed specifically so that local resources can be written into the empty white space. The poster was disseminated at the 2017 National Conference and Exhibition, discussed in an October 2017 AAP News article, and is available upon request until quantities are depleted. Request copies here.
Access state-by-state and national fact sheets that examine the intersection of the opioid epidemic, child welfare systems, and child health. These fact sheets also offer policy solutions that can support vulnerable children and families at both the state and federal level.
These training simulations are free to AAP members and provide participants with effective brief intervention techniques for addressing substance use and mental health concerns with adolescents. The virtual simulations, developed by Kognito, strive to increase comfort and improve the quality of care, ultimately leading to positive patient behavioral change.
To access the course, go to kognito.com/aap
1. Create a new account
2. Follow the onscreen instructions
3. Choose your course
4. Click “LAUNCH”
With funding from the American Academy of Addiction Psychiatry, the AAP held a webinar series on preventing, identifying, and treating opioid dependence.
Take special note of the “Take Home Points” document that accompanies each webinar.
1. Unraveling the Mystery of Acute and Chronic Pain in the Child & Adolescent
2. Putting the Pieces Together: Strategies for Pain Management
3. Co-Occurring Psychiatric Illness and Substance Use in Youth
4. Rational Pain Management in Children With Chronic Medical Conditions
5. Demystifying Buprenorphine Prescribing for Youth With Opioid Use Disorders
6. Understanding Neonatal Abstinence Syndrome for the General Pediatrician
Pediatricians must complete 8 hours of training and apply for a waiver to prescribe buprenorphine, a partial opioid agonist, to treat opioid use disorders in general medical settings. There are several options for training:
Online 8-Hour Course
AAP members can take the full 8-hour training online at www.aap.org/mat. Eight hours of CME credit will be awarded upon completion.
Live 8-Hour Course
If you are interested in delivering the 8-hour course in a live setting, OR you are interested in having an instructor travel to your location to give a live group training, email your request to firstname.lastname@example.org.
Half Online / Half Live Option
The course can be delivered in “halves.” If you are interested in delivering this format, or want to request an instructor to deliver this format, email your request to email@example.com.
All residents and fellows in Massachusetts are strongly encouraged to complete these education modules, or their own program adaptation.
8 professional presentations related to opioids, totaling 16 hours.
MMS Opioid Task Force
Membership of 21 physicians, residents, medical students.
4 meetings 2017
Given the complex needs of pregnant and postpartum women and their children, and the number of systems they encounter during critically important periods in their lives, ASAM provides policy recommendations on substance use, misuse, and SUDs during and following pregnancy.
A Joint Statement by the American Correctional Association (ACA) and ASAM support the use of evidence-based practices for the treatment of opioid use disorders for individuals within the criminal justice system.
This module describes the history of methadone maintenance and the effectiveness and key myths of opioid agonist treatment, explores empathizing with patients taking methadone or buprenorphine, and empowers clinicians to support patients and their significant others.
AANS Member: $75 Non-Member: $125
$56 for Members || $98 for Non-Members
The AAP was part of a coalition of medical professional organizations that developed this free online course. It is offered through two 30-minute sections and encourages prevention strategies for adolescents reporting no substance use and offers guidance for how to address substance use at all levels—from mild, to moderate, to severe. It also discusses safe prescribing practices and evidence-based treatments for teens with a substance use disorder. Brief clinician videos provide insights and tips to incorporate into practice.
The Maine Independent Clinical Information Service (MICIS) is a program of the Maine Medical Association. In 2017, there were 62 MICIS presentations (1, 2 and 3 hour programs) on opioid-related education as well as 3 1-hour webinars.
ASAM developed the National Practice Guideline to provide information on evidence-based treatment of opioid use disorder, and is the first to address all of the FDA-approved medications available to treat addiction involving opioid use and opioid overdose in a single document
New Hampshire Board Approved CME Regarding Opioid Prescribing
Beginning with the 2016-2017 CME reporting cycle, physicians who possess a DEA license will need to include 3 hours of Board approved opioid CME as part of the regular every-other year CME reporting cycle that coincides with license renewal.
The main goals of this course are to increase the number of pediatricians who understand how to assess and treat pain as well as how to identify patients at risk for misusing opioid medications. Case studies presented in this course provide the opportunity to apply the pain screening and management techniques to patient and family case situations.
This course reviews the types of chronic pain pediatricians are likely to see in their patients. The role of opioids in the treatment of chronic pain and Centers for Disease Control and Prevention (CDC) recommendations are discussed. This course is free.
AANS Member: $69 Non-Member: $119
Hegmann KT, et al., eds. “Opioids Guideline.” Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recovery in Workers. Reed Group, 2017.
Journal of Occupational & Environmental Medicine
Journal of Occupational & Environmental Medicine
The CO*RE/ASAM Opioid Prescribing: Safe Practice, Changing Lives course addresses the opioid public health crisis. This comprehensive course was developed by renowned experts from Collaborative for REMS Education (CO*RE) and incorporates all six units outlined in FDA blueprint for safe opioid prescribing. The updated course also provides necessary context for safe opioid prescribing by discussing biopsychosocial aspects of pain, the newest clinical guidelines on the treatment of chronic pain, and state policies about prescribing opioids.
This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. ASAM also provides the additional 16 hours that are required for NPs and PAs
The Pennsylvania Department of Health (DOH) issued a health advisory regarding carfentanil-related overdoses in several areas of Pennsylvania. DOH says that some areas have seen significant numbers of these overdoses, including some that were fatal.
The ASAM Fundamentals of Addiction Medicine 40-Hour Program is a needs-based curriculum that addresses the most important areas of knowledge and skills for the diagnosis and treatment of substance use disorders by providers new to the field of addiction medicine, such as primary care physicians, clinicians and general psychiatrists, who see patients at risk for or with substance use disorders.
ASCO University Faculty:
- Eduardo Bruera, MD
- Kimberly Chow, NP
- Judith Paice, PhD, RN
#C184 – Core Concepts in Pain Management II: Safe Opioid Prescribing Practical Considerations, Unintended Consequences, and Legal Issues
#C157 – Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome
PCSS-MAT is comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder, including courses satisfying the DATA-2000 waiver.
DVD and CD order form.
Approved by the NM Medical Board to meet five  hour s of pain management education requirements and accredited for CME December 2014 through November 2019.
The Nebraska Department of Justice, in conjunction with the Nebraska Department of Health and Human Services, the University of Nebraska Medical Center, the U.S. Attorney’s Office and other key stakeholders working to end the opioid epidemic.